Core Viewpoint - Goldman Sachs is set to release its first-quarter 2025 earnings on April 14, with expectations of revenue growth but a slight decline in earnings estimates compared to the previous quarter [1][5]. Revenue and Earnings Estimates - The Zacks Consensus Estimate for Q1 2025 revenues is $15.16 billion, reflecting a 6.6% increase from the same quarter last year [5]. - The earnings estimate has been revised downward to $12.72 per share, indicating a 9.8% increase from the year-ago quarter [5]. Market Conditions and Performance Drivers - Market-making revenues are expected to rise due to solid client activities and market volatility driven by tariff impacts and Federal Reserve monetary policy [7]. - Investment banking (IB) fees are projected to decline by 8.8% to $1.88 billion, influenced by underperformance in global M&A activities [10][11]. - Net Interest Income (NII) is estimated at $4.67 billion, showing significant growth from $2.35 billion in the prior quarter, supported by stable interest rates [12]. Expense Trends - Increased expenses are anticipated due to investments in technology, market development, and higher transaction-based costs from elevated client activity [13]. Earnings Surprise History - Goldman Sachs has a strong earnings surprise history, with an average surprise of 26.87% over the last four quarters [3]. Stock Performance and Valuation - In Q1 2025, Goldman shares underperformed compared to its industry but outperformed the S&P 500 index [16]. - The current forward P/E ratio for Goldman is 9.78X, which is lower than the industry average of 10.59X and significantly lower than peers like JP Morgan and Morgan Stanley [18][20]. Strategic Initiatives - The company plans to enhance its lending services to private equity and asset managers and aims to expand its private credit portfolio to $300 billion over five years [22]. - Goldman Sachs has a strong liquidity position, supporting capital distribution activities, including a recent 9.1% increase in its common stock dividend [23].

Core Viewpoint - CSX is anticipated to report a year-over-year decline in earnings and revenues for the quarter ended March 2025, which could significantly influence its stock price depending on the actual results compared to estimates [1][2]. Earnings Expectations - The upcoming earnings report is expected to be released on April 16, 2025, with a consensus estimate of $0.38 per share, reflecting a year-over-year decrease of 17.4% [3]. - Revenues are projected to be $3.55 billion, down 3.7% from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 0.2% higher in the last 30 days, indicating a slight reassessment by analysts [4]. - The Most Accurate Estimate for CSX is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -0.79%, suggesting a bearish outlook from analysts [10][11]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict the likelihood of actual earnings deviating from consensus estimates, with a strong predictive power for positive readings [7][8]. - CSX currently holds a Zacks Rank of 3, which complicates the prediction of an earnings beat [11]. Historical Performance - In the last reported quarter, CSX was expected to post earnings of $0.43 per share but delivered $0.42, resulting in a surprise of -2.33% [12]. - Over the past four quarters, CSX has beaten consensus EPS estimates two times [13]. Conclusion - CSX does not appear to be a compelling candidate for an earnings beat, and investors should consider other factors when making decisions regarding the stock ahead of the earnings release [16].

Core Viewpoint - Kinder Morgan is expected to report a year-over-year increase in earnings and revenues, but actual results compared to estimates will significantly impact its stock price [1][2]. Earnings Expectations - The consensus estimate for Kinder Morgan's quarterly earnings is $0.35 per share, reflecting a 2.9% increase year-over-year, with revenues projected at $4.14 billion, up 7.7% from the previous year [3]. - The consensus EPS estimate has been revised 1.9% higher in the last 30 days, indicating a reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that the Most Accurate Estimate is lower than the consensus estimate, resulting in an Earnings ESP of -2.90%, indicating a bearish outlook from analysts [10][11]. - A positive Earnings ESP is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3, which increases the likelihood of a positive surprise [8]. Historical Performance - Kinder Morgan has only beaten consensus EPS estimates once in the last four quarters, with a recent surprise of -3.03% when it reported earnings of $0.32 per share against an expectation of $0.33 [12][13]. Conclusion - Kinder Morgan does not appear to be a compelling candidate for an earnings beat, and investors should consider other factors before making investment decisions [16].

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Solventum (SOLV) , which belongs to the Zacks Medical Services industry, could be a great candidate to consider.This health care company has an established record of topping earnings estimates, especially when looking at the previous two reports. The company boasts an average surprise for the past two quarters of 13.24%.For the last reported quarter, S ...

Core Viewpoint - JPMorgan is set to report its Q1 2025 earnings on April 11, with expectations of modest performance compared to previous quarters due to various economic pressures and rising costs [1][2][3]. Financial Performance Expectations - The Zacks Consensus Estimate for Q1 2025 revenues is $43.01 billion, indicating a 2.6% year-over-year growth [2]. - The earnings estimate for the upcoming quarter has been revised slightly upward to $4.60, reflecting a nearly 1% decline from the prior year due to increased provisions for credit losses and higher operating expenses [3][4]. Revenue Drivers - Net Interest Income (NII) is expected to be around $23.31 billion, showing a 1% growth year-over-year, supported by stable funding costs [9]. - Investment Banking (IB) fees are projected to grow by 13% year-over-year, with estimates for IB revenues at $2.61 billion [10][14]. - Markets revenues are anticipated to increase in low double digits, with equity markets revenues estimated at $3.1 billion and fixed-income markets revenues at $5.85 billion [15][16]. Cost and Expense Outlook - Non-interest expenses are expected to rise to $23.8 billion, reflecting a 4.5% increase year-over-year due to expansion efforts and technology investments [18]. - The provision for credit losses is estimated at $2.45 billion, indicating a cautious approach to potential loan defaults [19]. Asset Quality Concerns - The consensus estimate for non-performing loans (NPLs) is $9.32 billion, suggesting a 21.5% increase year-over-year, while non-performing assets (NPAs) are expected to rise to $9.82 billion [20][21]. Market Position and Valuation - JPMorgan's stock is currently trading at a forward P/E of 12.40X, above the industry average of 11.66X, indicating a premium valuation compared to peers like Citigroup and Bank of America [26]. - The company continues to leverage its scale and size, with the acquisition of First Republic Bank in 2023 enhancing its financial position [29]. Strategic Outlook - The company is focused on expanding its footprint and capitalizing on cross-selling opportunities, which may lead to higher investment-related expenses but are expected to benefit long-term prospects [29]. - Management's comments on NII and IB business prospects during the upcoming earnings call will be crucial for investors [30].

Core Viewpoint - Progressive (PGR) is anticipated to report a year-over-year increase in earnings driven by higher revenues, with a consensus outlook suggesting a positive earnings picture that could influence its stock price in the near term [1][3]. Earnings Expectations - The consensus EPS estimate for Progressive is $4.60 per share, reflecting a year-over-year increase of +23.3% [3]. - Expected revenues for the quarter are $20.38 billion, which is a 19.3% increase from the same quarter last year [3]. Estimate Revisions - Over the last 30 days, the consensus EPS estimate has been revised 0.49% higher, indicating a collective reassessment by covering analysts [4]. - The Most Accurate Estimate for Progressive is higher than the Zacks Consensus Estimate, resulting in a positive Earnings ESP of +4.31% [10][11]. Earnings Surprise Prediction - A positive Earnings ESP is a strong indicator of an earnings beat, especially when combined with a Zacks Rank of 1 (Strong Buy), 2 (Buy), or 3 (Hold) [8]. - Stocks with this combination have historically produced a positive surprise nearly 70% of the time [8]. Historical Performance - In the last reported quarter, Progressive exceeded the expected earnings of $3.43 per share by delivering $4.08, resulting in a surprise of +18.95% [12]. - The company has beaten consensus EPS estimates in all of the last four quarters [13]. Conclusion - Progressive is positioned as a compelling candidate for an earnings beat, but investors should consider other factors that may influence stock performance beyond earnings results [16].

For the quarter ended February 2025, UniFirst (UNF) reported revenue of $602.22 million, up 2% over the same period last year. EPS came in at $1.40, compared to $1.22 in the year-ago quarter.The reported revenue represents a surprise of -0.14% over the Zacks Consensus Estimate of $603.04 million. With the consensus EPS estimate being $1.31, the EPS surprise was +6.87%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expec ...

Core Viewpoint - Reinsurance Group of America (RGA) shares are trading at a discount compared to the industry average, indicating potential investment opportunities due to its strong fundamentals and growth prospects [1][2]. Financial Metrics - RGA has a market capitalization of $13.09 billion and a forward price-to-book value of 1.2X, lower than the industry average of 1.83X, the Finance sector's 4.05X, and the S&P 500 Composite's 7.89X [1][2]. - The average trading volume over the last three months was 0.5 million shares [2]. Price Performance - RGA's shares have gained 2.4% over the past year, underperforming the industry growth of 13.8%, the Finance sector's return of 15.4%, and the S&P 500 composite's appreciation of 8.1% [3]. Earnings Surprise History - RGA has a solid earnings surprise history, beating estimates in three of the last four quarters with an average surprise of 14.67% [4]. Growth Projections - The Zacks Consensus Estimate for RGA's 2025 earnings per share indicates a year-over-year increase of 1.8%, with revenues projected at $24.22 billion, reflecting a 7.3% improvement [5]. - For 2026, earnings per share and revenues are expected to increase by 8.6% and 8.7%, respectively, from the 2024 estimates [5]. Historical Earnings Growth - RGA's earnings have grown by 15.3% over the past five years, outperforming the industry average of 7.8% [6]. Return on Invested Capital - RGA's return on invested capital (ROIC) has consistently increased, reaching 6.3% in the trailing 12 months, significantly higher than the industry average of 0.6% [7]. Market Position and Strategy - RGA is a leader in the U.S. and Latin American markets, with a strong product line and capabilities that contribute to stable earnings and capital generation [10]. - In Canada, RGA holds a significant block of in-force business, which is expected to drive future earnings, particularly in longevity insurance [11]. - The company is well-capitalized and plans to deploy capital in attractive growth opportunities while returning excess capital to shareholders [12][14]. Technological Integration - RGA is enhancing its product offerings through technological advancements and is recognized as a global leader in biometric liability reinsurance [13]. Capital Management - The company effectively manages capital through share buybacks, dividends, and prudent investments, aiming to balance growth opportunities with shareholder returns [14]. Long-term Outlook - RGA's diversified business model, favorable longevity experience, and effective capital deployment strategies position it well for long-term growth [15].

Core Insights - Nike reported quarterly earnings of $0.54 per share, exceeding the Zacks Consensus Estimate of $0.28 per share, but down from $0.98 per share a year ago, representing an earnings surprise of 92.86% [1] - The company generated revenues of $11.27 billion for the quarter ended February 2025, surpassing the Zacks Consensus Estimate by 2.13%, but down from $12.43 billion year-over-year [2] - Nike has consistently surpassed consensus EPS estimates over the last four quarters, achieving this four times [2] Earnings Performance - The earnings surprise of 92.86% indicates strong performance relative to expectations, with a previous quarter's earnings of $0.78 per share also exceeding estimates [1][2] - The current consensus EPS estimate for the upcoming quarter is $0.27, with projected revenues of $11.17 billion, while the estimate for the current fiscal year is $2.06 on revenues of $46.24 billion [7] Market Position and Outlook - Nike shares have declined approximately 3.5% since the beginning of the year, mirroring the S&P 500's decline of -3.5% [3] - The company's Zacks Rank is currently 3 (Hold), indicating expected performance in line with the market in the near future [6] - The Shoes and Retail Apparel industry, to which Nike belongs, is currently ranked in the bottom 9% of over 250 Zacks industries, suggesting potential challenges ahead [8]

Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for Walgreens Boots Alliance (WBA) despite an increase in revenues, with actual results being crucial for stock price movement [1][3]. Earnings Expectations - The expected quarterly earnings per share (EPS) for Walgreens is $0.53, reflecting a year-over-year decrease of 55.8% [3]. - Revenues are projected to reach $37.92 billion, which is a 2.4% increase from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 1.82% higher in the last 30 days, indicating a positive reassessment by analysts [4]. - A positive Earnings ESP of +9.39% suggests that analysts are optimistic about Walgreens' earnings prospects [10][11]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive reading is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1 (Strong Buy), 2 (Buy), or 3 (Hold) [8]. - Walgreens currently holds a Zacks Rank of 2, enhancing the likelihood of beating the consensus EPS estimate [11]. Historical Performance - In the last reported quarter, Walgreens exceeded the expected EPS of $0.37 by delivering $0.51, resulting in a surprise of +37.84% [12]. - Over the past four quarters, Walgreens has beaten consensus EPS estimates three times [13]. Conclusion - While Walgreens is positioned as a compelling earnings-beat candidate, other factors should also be considered when evaluating the stock ahead of its earnings release [16].